Literature DB >> 29532227

Predictors of recurrence and survival of pathological T1N0M0 invasive adenocarcinoma following lobectomy.

Yiyang Wang1, Difan Zheng2, Jiajie Zheng1, Qingyuan Huang1, Baohui Han3, Jie Zhang4, Heng Zhao1, Haiquan Chen5,6.   

Abstract

BACKGROUND: This retrospective research was designed to investigate the relationship between pT1N0M0 invasive adenocarcinoma (IADC) harboring solid (SOL) and/or micropapillary (MIP) components and its prognosis following lobectomy.
METHODS: Clinical data of pT1N0M0 IADC patients were retrospectively collected from Shanghai Chest Hospital. Survival curves were plotted by Kaplan-Meier methods. Multivariable cox regressions were conducted to discover the independent risk factors of recurrence-free survival (RFS) and overall survival (OS), through which nomograms were performed to visualize the risk of recurrences and outcomes in personalized information.
RESULTS: Totally, 1965 patients were enrolled, including 248 harboring SOL/MIP and 1717 not. IADC demonstrated worse 5-year RFS (81.9 vs. 92.2%, p < 0.001) and OS (85.7 vs. 94.4%, p < 0.001) when harboring SOL and/or MIP components. And this status became an independent factor associated with poorer RFS (HR 2.445, 95% CI 1.565-3.821, p < 0.001) and OS (HR 2.139, 95% CI 1.180-3.878, p = 0.012) instead of novel classification of IADC predominant patterns. No difference existed between SOL/MIP predominant and minor patterns. In addition, age > 60, smoking, post-chemotherapy and T1b were all indicating poorer RFS and smoking was also related with worse OS. The c-indexes of nomograms were 0.723 for RFS (95% CI, 0.662-0.784) and 0.703 for OS (95% CI, 0.629-0.777) respectively.
CONCLUSIONS: Once the pT1N0M0 IADC harboring SOL/MIP, it strongly indicated the worse clinical recurrence and survival outcome, no matter whether the SOL and/or MIP was predominant. Smoking was correlated with worse prognosis for those patients. Age > 60 and stage T1b also indicated poorer RFS. Whether post-chemotherapy was harmful to pT1N0M0 IADC patients needed further research.

Entities:  

Keywords:  Lung invasive adenocarcinoma; Nomogram; Pathological T1N0M0 stage; Pathological subtypes

Mesh:

Year:  2018        PMID: 29532227     DOI: 10.1007/s00432-018-2622-8

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  32 in total

1.  Patterns of surgical care of lung cancer patients.

Authors:  Alex G Little; Valerie W Rusch; James A Bonner; Laurie E Gaspar; Mark R Green; W Richard Webb; Andrew K Stewart
Journal:  Ann Thorac Surg       Date:  2005-12       Impact factor: 4.330

2.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

Review 3.  Low-dose computed tomographic screening for lung cancer.

Authors:  Jared D Christensen; Caroline Chiles
Journal:  Clin Chest Med       Date:  2015-04-11       Impact factor: 2.878

Review 4.  Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma.

Authors:  William D Travis; Kavita Garg; Wilbur A Franklin; Ignacio I Wistuba; Bradley Sabloff; Masayuki Noguchi; Ryutaro Kakinuma; Maureen Zakowski; Michelle Ginsberg; Robert Padera; Francine Jacobson; Bruce E Johnson; Fred Hirsch; Elizabeth Brambilla; Douglas B Flieder; Kim R Geisinger; Frederik Thunnisen; Keith Kerr; David Yankelevitz; Teri J Franks; Jeffrey R Galvin; Douglas W Henderson; Andrew G Nicholson; Philip S Hasleton; Victor Roggli; Ming-Sound Tsao; Federico Cappuzzo; Madeline Vazquez
Journal:  J Clin Oncol       Date:  2005-05-10       Impact factor: 44.544

5.  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification predicts occult lymph node metastasis in clinically mediastinal node-negative lung adenocarcinoma.

Authors:  Yi-Chen Yeh; Kyuichi Kadota; Jun-ichi Nitadori; Camelia S Sima; Nabil P Rizk; David R Jones; William D Travis; Prasad S Adusumilli
Journal:  Eur J Cardiothorac Surg       Date:  2015-09-15       Impact factor: 4.191

6.  Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer.

Authors:  Michelle S Ludwig; Michael Goodman; Daniel L Miller; Peter A S Johnstone
Journal:  Chest       Date:  2005-09       Impact factor: 9.410

7.  The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

Authors:  Peter Goldstraw; John Crowley; Kari Chansky; Dorothy J Giroux; Patti A Groome; Ramon Rami-Porta; Pieter E Postmus; Valerie Rusch; Leslie Sobin
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

8.  Prognostic Role of Subtype Classification in Small-Sized Pathologic N0 Invasive Lung Adenocarcinoma.

Authors:  Tomoharu Yoshiya; Takahiro Mimae; Yasuhiro Tsutani; Norifumi Tsubokawa; Shinsuke Sasada; Yoshihiro Miyata; Kei Kushitani; Yukio Takeshima; Shuji Murakami; Hiroyuki Ito; Haruhiko Nakayama; Morihito Okada
Journal:  Ann Thorac Surg       Date:  2016-06-23       Impact factor: 4.330

Review 9.  Lymphovascular invasion as a prognostic indicator in stage I non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Nathan M Mollberg; Carrie Bennette; Eric Howell; Leah Backhus; Beth Devine; Mark K Ferguson
Journal:  Ann Thorac Surg       Date:  2014-01-11       Impact factor: 4.330

10.  Prediction of survival in patients with thin melanoma: results from a multi-institution study.

Authors:  Andrea Maurichi; Rosalba Miceli; Tiziana Camerini; Luigi Mariani; Roberto Patuzzo; Roberta Ruggeri; Gianfranco Gallino; Elena Tolomio; Gabrina Tragni; Barbara Valeri; Andrea Anichini; Roberta Mortarini; Daniele Moglia; Giovanni Pellacani; Sara Bassoli; Caterina Longo; Pietro Quaglino; Nicola Pimpinelli; Lorenzo Borgognoni; Daniele Bergamaschi; Catherine Harwood; Odysseas Zoras; Mario Santinami
Journal:  J Clin Oncol       Date:  2014-07-07       Impact factor: 44.544

View more
  6 in total

1.  [Pattern of Recurrence and Metastasis after Radical Resection of 
Non-small Cell Lung Cancer].

Authors:  Xianping Liu; Xiao Li; Fan Yang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2022-01-20

2.  Genomics Analysis and Nomogram Risk Prediction of Occult Lymph Node Metastasis in Non-Predominant Micropapillary Component of Lung Adenocarcinoma Measuring ≤ 3 cm.

Authors:  Kun Wang; Mengchao Xue; Jianhao Qiu; Ling Liu; Yueyao Wang; Rongyang Li; Chenghao Qu; Weiming Yue; Hui Tian
Journal:  Front Oncol       Date:  2022-07-13       Impact factor: 5.738

3.  Establishment and Validation of a Predictive Nomogram for Postoperative Survival of Stage I Non-Small Cell Lung Cancer.

Authors:  Zhi-Hui Wang; Lili Deng
Journal:  Int J Gen Med       Date:  2022-09-14

4.  Clinical implication of minimal presence of solid or micropapillary subtype in early-stage lung adenocarcinoma.

Authors:  Sun Ha Choi; Ji Yun Jeong; Shin Yup Lee; Kyung Min Shin; Shin Young Jeong; Tae-In Park; Young Woo Do; Eung Bae Lee; Yangki Seok; Won Kee Lee; Ji Eun Park; Sunji Park; Yong Hoon Lee; Hyewon Seo; Seung Soo Yoo; Jaehee Lee; Seung-Ick Cha; Chang Ho Kim; Jae Yong Park
Journal:  Thorac Cancer       Date:  2020-11-24       Impact factor: 3.223

5.  Prognostic impact of micropapillary component in patients with node-negative subcentimeter lung adenocarcinoma: A Chinese cohort study.

Authors:  Jie Yao; Erjia Zhu; Ming Li; Jinshi Liu; Lei Zhang; Honggang Ke; Hang Su; Huikang Xie; Guanxin Xu; Ling Zhu; Junqiang Fan; Chang Chen
Journal:  Thorac Cancer       Date:  2020-10-15       Impact factor: 3.500

6.  Different pathologic types of early stage lung adenocarcinoma have different post-operative recurrence patterns.

Authors:  Xianping Liu; Kunkun Sun; Fan Yang; Xizhao Sui; Guanchao Jiang; Jun Wang; Xiao Li
Journal:  Thorac Cancer       Date:  2021-06-28       Impact factor: 3.500

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.